CryoPort
IPOHomepage - Cryoport, Inc
Public · Nashville, United States · Founded 2005 · $326.0M raised
- Headquarters
- Nashville, Tennessee
- Employees
- 501–1000
- Founded
- 2005
- Business Model
- B2B
- Website
- cryoportinc.com
- Total Funding
- $326.0M
- Last Round
- $51.0M Series CFeb 2021
- Rounds
- 2
- Type
- Public
About
Cryoport, Inc. (Nasdaq: CYRX) is a global leader in temperature-controlled supply chain solutions for the life sciences industry, serving the biopharma, animal health, and reproductive medicine markets. The company operates through three subsidiaries — Cryoport Systems, MVE Biological Solutions, and CRYOGENE — with 50 strategic locations across the Americas, EMEA, and APAC. As the world's largest manufacturer of cryogenic systems, Cryoport provides bio-logistics, bio-storage, bio-processing, and cryogenic solutions critical to cell and gene therapies.
Summary
CryoPort is a Biotech company based in Nashville, United States, founded in 2005. It has raised $326.0M in total across 2 rounds, most recently a $51.0M Series C round in Feb 2021. Investors include Blackstone.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
